Cambridge Investment Research Advisors, Inc.
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1419186
FAIRFIELD, IA
Position in VRTX
as of Mar 31, 2026
· filed Apr 30, 2026
Position Value
$7,124,545
+$615,656 QoQ
Shares Held
15,955
+11.1% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Cambridge Investment Research Advisors, Inc. holds $49,299,867 across 75 Biotechnology names. VRTX ranks #1 (14.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
15,955 | $7,124,545 | |
| 2 | EXEL |
Exelixis, Inc.
|
159,749 | $6,851,634 | |
| 3 | NKTR |
Nektar Therapeutics
|
56,055 | $4,033,157 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4,832 | $3,733,396 | |
| 5 | IBRX |
ImmunityBio, Inc.
|
284,704 | $2,183,679 | |
| 6 | BBIO |
BridgeBio Pharma, Inc.
|
29,059 | $2,157,921 | |
| 7 | CRSP |
CRISPR Therapeutics AG
|
37,992 | $1,807,279 | |
| 8 | CORT |
Corcept Therapeutics Inc
|
42,754 | $1,723,413 |
All Filings in VRTX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $7,124,545 | 15,955 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $6,508,889 | 14,357 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $5,528,781 | 14,117 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $7,714,870 | 17,329 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $7,917,595 | 16,331 | Shares | Sole | 2025-04-22 | |
| 2024-12-31 | $5,066,368 | 12,581 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $6,751,566 | 14,517 | Shares | Sole | 2024-10-28 | |
| 2024-06-30 | $6,525,988 | 13,923 | Shares | Sole | 2024-07-26 | |
| 2024-03-31 | $7,806,336 | 18,675 | Shares | Sole | 2024-04-24 | |
| 2023-12-31 | $6,454,089 | 15,862 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $4,541,136 | 13,059 | Shares | Sole | 2023-10-24 | |
| 2023-06-30 | $4,588,202 | 13,038 | Shares | Sole | 2023-07-13 | |
| 2023-03-31 | $3,964,525 | 12,583 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $3,886,112 | 13,457 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $4,184,432 | 14,452 | Shares | Sole | 2022-10-17 | |
| 2022-06-30 | $3,945,623 | 14,002 | Shares | Sole | 2022-07-13 | |
| 2022-03-31 | $3,378,778 | 12,947 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $2,676,704 | 12,189 | Shares | Sole | 2022-02-03 | |
| 2021-09-30 | $2,219,125 | 12,234 | Shares | Sole | 2021-11-02 | |
| 2021-06-30 | $2,676,033 | 13,272 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $2,617,145 | 12,179 | Shares | Sole | 2021-05-07 | |
| 2020-12-31 | $2,187,563 | 9,256 | Shares | Sole | 2021-02-04 | |
| 2020-09-30 | $2,400,642 | 8,822 | Shares | Sole | 2020-10-29 | |
| 2020-06-30 | $6,342,692 | 21,848 | Shares | Sole | 2020-07-27 | |
| 2020-03-31 | $2,527,029 | 10,620 | Shares | Sole | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||